Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NASDAQ:CADL
Recent news which mentions NASDAQ:CADL
Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
June 14, 2024
Tickers
CADL
Tags
NASDAQ:CADL
From
News Direct
Candel Therapeutics’ (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers
June 07, 2024
Tickers
CADL
Tags
NASDAQ:CADL
From
News Direct
Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer
June 03, 2024
Tickers
CADL
Tags
NASDAQ:CADL
From
News Direct
CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024
May 14, 2024
Tickers
CADL
Tags
Earnings Reports
CADL
NASDAQ:CADL
From
InvestorPlace
CADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023
March 28, 2024
Tickers
CADL
Tags
NASDAQ:CADL
Market News
Earnings Reports
From
InvestorPlace
Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors
March 15, 2024
Tickers
CADL
Tags
NASDAQ:CADL
From
News Direct
Moving Fast: Candel’s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
February 28, 2024
Tickers
CADL
Tags
NASDAQ:CADL
From
News Direct
Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies
February 15, 2024
Tickers
CADL
Tags
NASDAQ:CADL
From
News Direct
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.